NO996439L - Proliposompulvere for inhalering stabilisert med tokoferol - Google Patents

Proliposompulvere for inhalering stabilisert med tokoferol

Info

Publication number
NO996439L
NO996439L NO996439A NO996439A NO996439L NO 996439 L NO996439 L NO 996439L NO 996439 A NO996439 A NO 996439A NO 996439 A NO996439 A NO 996439A NO 996439 L NO996439 L NO 996439L
Authority
NO
Norway
Prior art keywords
tocopherol
inhalation
stabilized
powders
proliposome
Prior art date
Application number
NO996439A
Other languages
English (en)
Norwegian (no)
Other versions
NO996439D0 (no
Inventor
Katarina Bystroem
Per-Gunnar Nilsson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO996439D0 publication Critical patent/NO996439D0/no
Publication of NO996439L publication Critical patent/NO996439L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO996439A 1997-06-27 1999-12-23 Proliposompulvere for inhalering stabilisert med tokoferol NO996439L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88441997A 1997-06-27 1997-06-27
PCT/SE1998/001090 WO1999000111A1 (en) 1997-06-27 1998-06-08 Proliposome powders for inhalation stabilised by tocopherol

Publications (2)

Publication Number Publication Date
NO996439D0 NO996439D0 (no) 1999-12-23
NO996439L true NO996439L (no) 2000-02-28

Family

ID=25384589

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996439A NO996439L (no) 1997-06-27 1999-12-23 Proliposompulvere for inhalering stabilisert med tokoferol

Country Status (18)

Country Link
EP (1) EP1001749A1 (et)
JP (1) JP2002510311A (et)
KR (1) KR20010014163A (et)
CN (1) CN1260713A (et)
AU (1) AU729100B2 (et)
BR (1) BR9810280A (et)
CA (1) CA2295028A1 (et)
EE (1) EE9900601A (et)
HU (1) HUP0003207A3 (et)
ID (1) ID23192A (et)
IL (1) IL133478A0 (et)
IS (1) IS5304A (et)
NO (1) NO996439L (et)
NZ (1) NZ501672A (et)
PL (1) PL337723A1 (et)
SK (1) SK184899A3 (et)
TR (1) TR199903271T2 (et)
WO (1) WO1999000111A1 (et)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138310A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
EP1138311A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
EP1138313A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
ES2462541T3 (es) * 2005-06-09 2014-05-23 Meda Ab Método y composición para el tratamiento de trastornos inflamatorios
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2014180827A1 (en) * 2013-05-06 2014-11-13 Dsm Ip Assets B. V. Powderous vitamin e formulation
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CN105078963B (zh) * 2015-09-29 2018-06-22 中山大学 α-生育酚在制备治疗血吸虫病药物中的应用
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
AU2019308326B2 (en) 2018-07-20 2025-07-31 Lipocine Inc. Liver disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05507090A (ja) * 1990-05-08 1993-10-14 リポサーム　テクノロジー　インコーポレイテッド 直接噴霧乾燥された薬剤／脂質粉末組成物
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.

Also Published As

Publication number Publication date
KR20010014163A (ko) 2001-02-26
IS5304A (is) 1999-12-15
AU729100B2 (en) 2001-01-25
HUP0003207A3 (en) 2001-03-28
SK184899A3 (en) 2000-05-16
CN1260713A (zh) 2000-07-19
BR9810280A (pt) 2000-09-12
TR199903271T2 (en) 2000-08-21
IL133478A0 (en) 2001-04-30
CA2295028A1 (en) 1999-01-07
AU7945698A (en) 1999-01-19
JP2002510311A (ja) 2002-04-02
NO996439D0 (no) 1999-12-23
NZ501672A (en) 2001-06-29
WO1999000111A1 (en) 1999-01-07
PL337723A1 (en) 2000-08-28
HUP0003207A2 (hu) 2001-02-28
EE9900601A (et) 2000-08-15
EP1001749A1 (en) 2000-05-24
ID23192A (id) 2000-03-23

Similar Documents

Publication Publication Date Title
NO996439L (no) Proliposompulvere for inhalering stabilisert med tokoferol
GR860066B (en) Process for the preparation of drug-containing chlorofluorocarbon aerosol propellent formulations
NO171443C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende syntetiske lipider
ES8308211A1 (es) Un metodo de preparar un polvo seco que comprende un farmaco encapsulado con etilcelulosa, poli (acetato de vinilo) u otros polimeros.
AU567271B2 (en) Lyophilization of oil in water emulsion to give galenic form for oral administration
HU900708D0 (en) Process for preparation of substituted 1,3-oxathiolanes and pharmaceutical preparations containing them
GB2113568B (en) New emulsifying system based on a fatty acid of a protein condensate, polyoxyethyleneated sterol and phosphatide, suitable for use for the preparation of cosmetic or pharmaceutical compositions
ZA792284B (en) Structural analogs of natural phosphatides processes for their preparation,and pharmaceutical preparations thereof
ATE172636T1 (de) Liposomales verabreichungssystem für biologisch aktive stoffe
CA2039491A1 (en) Stable compositions for parenteral administration and method of making same
AU2581888A (en) Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations
DE3267673D1 (en) Phospholipid derivatives, processes for preparation thereof and pharmaceutical composition of the same
DE3366393D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
BR9712125A (pt) Formulação farmaucêutica em aerosol, uso de uma mistura, produto farmacêutico, e, processo de administração de budesonida a um paciente
DK62187A (da) Farmaceutisk praeparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf
PL307255A1 (en) Polysubstituted derivatives of 3-acylamine 5-phenyl-1,4-benzoazepin-2-one, method of obtaining them and pharmaceutical preparations containing such derivatives
AU8215791A (en) Method for preparing a lipoprotein modified by the incorporation of a lipophilic active substance
AU2764888A (en) Continuous process for the preparation of gelatin from powdered bone, and gelatin obtained
AU2923389A (en) A pharmaceutical composition
DE69414821D1 (de) Diätetische cholesterinsenkende zubereitungen, die sojaproteine und sitosterine enthalten
AU4246489A (en) New benzoxazolinone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DK0740547T3 (da) Liposomer indeholdende deri indkapslede proteiner, fremgangsmåde til deres fremstilling, samt farmaceutiske og kosmetiske p
EP0652755A1 (en) THERAPEUTIC USE OF PHOSPHORYL-L-SERINE-N-ACYL-SPHINGOSINE.
HUT44764A (en) Process for producing new sulfonamidoethyl derivatives and pharmaceutical preparations comprising them as active substance
FR2656606B1 (fr) Utilisation de derives du 9,10-dihydrophenanthrene pour la preparation d'un medicament anti-tumoral, application a titre de medicaments de derives du 9,10-dihydrophenanthrene et produits derives de cette structure.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application